JP2024507528A5 - - Google Patents
Info
- Publication number
- JP2024507528A5 JP2024507528A5 JP2023550249A JP2023550249A JP2024507528A5 JP 2024507528 A5 JP2024507528 A5 JP 2024507528A5 JP 2023550249 A JP2023550249 A JP 2023550249A JP 2023550249 A JP2023550249 A JP 2023550249A JP 2024507528 A5 JP2024507528 A5 JP 2024507528A5
- Authority
- JP
- Japan
- Prior art keywords
- microsphere
- polymer
- lurasidone
- formulation according
- biodegradable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152943P | 2021-02-24 | 2021-02-24 | |
| US63/152,943 | 2021-02-24 | ||
| US202263267403P | 2022-02-01 | 2022-02-01 | |
| US63/267,403 | 2022-02-01 | ||
| PCT/US2022/070807 WO2022183196A1 (en) | 2021-02-24 | 2022-02-24 | Microsphere formulations comprising lurasidone and methods for making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507528A JP2024507528A (ja) | 2024-02-20 |
| JP2024507528A5 true JP2024507528A5 (enExample) | 2025-02-25 |
Family
ID=82900191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550249A Pending JP2024507528A (ja) | 2021-02-24 | 2022-02-24 | ルラシドンを含むミクロスフェア製剤ならびにその製造方法および使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11992559B2 (enExample) |
| EP (1) | EP4297753A4 (enExample) |
| JP (1) | JP2024507528A (enExample) |
| KR (1) | KR20230157365A (enExample) |
| AU (1) | AU2022226584A1 (enExample) |
| CA (1) | CA3210098A1 (enExample) |
| IL (1) | IL304650A (enExample) |
| MX (1) | MX2023009754A (enExample) |
| WO (1) | WO2022183196A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119424341A (zh) * | 2023-08-02 | 2025-02-14 | 珠海市华海康医药科技有限责任公司 | 一种注射用药物缓释微球及其制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| US5288502A (en) | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres |
| EP0724432B1 (en) | 1993-10-22 | 2002-09-18 | Genentech, Inc. | Methods and compositions for microencapsulation of antigens for use as vaccines |
| ATE288270T1 (de) | 1993-11-19 | 2005-02-15 | Janssen Pharmaceutica Nv | Mikroverkapselte 1,2-benzazole |
| PT1615959E (pt) | 2003-04-10 | 2013-08-29 | Evonik Corp | Um método para a produção de micropartículas à base de emulsão |
| WO2005009356A2 (en) | 2003-07-15 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Method for the preparation of controlled release formulations |
| JP2008518881A (ja) | 2003-07-18 | 2008-06-05 | オークウッド ラボラトリーズ，エル．エル．シー． | 高分子組成物中の高分子の分子量低下、不純物形成およびゲル化の防止 |
| AU2004259209A1 (en) | 2003-07-23 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Controlled release compositions |
| WO2006134864A1 (ja) | 2005-06-13 | 2006-12-21 | Dainippon Sumitomo Pharma Co., Ltd. | 可溶化型製剤 |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| US8202524B2 (en) | 2006-08-31 | 2012-06-19 | Sk Chemicals Co., Ltd. | Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby |
| CA2709712C (en) | 2007-12-20 | 2016-05-10 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles having a low residual solvent volume |
| KR20120035183A (ko) | 2009-06-10 | 2012-04-13 | 선오비온 파마슈티컬스 인코포레이티드 | 히스타민 ｈ3 역 작용제 및 길항제, 및 이의 사용 방법 |
| AU2010339689B2 (en) | 2010-01-07 | 2015-02-19 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
| US10335366B2 (en) * | 2010-05-31 | 2019-07-02 | Laboratorios Farmacéuticos Rovi, S.A. | Risperidone or paliperidone implant formulation |
| CN107595771A (zh) | 2010-10-18 | 2018-01-19 | 大日本住友制药株式会社 | 注射用缓释制剂 |
| SG190009A1 (en) | 2010-11-24 | 2013-06-28 | Univ Nanyang Tech | Method for encapsulating particles |
| AU2011348085B2 (en) | 2010-12-23 | 2016-12-08 | Alkermes Pharma Ireland Limited | Multi- API loading prodrugs |
| WO2013142205A1 (en) | 2012-03-19 | 2013-09-26 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising benzyl alcohol |
| WO2014076712A2 (en) | 2012-11-14 | 2014-05-22 | Hetero Research Foundation | Lurasidone hydrochloride solid dispersion |
| US9393211B2 (en) | 2013-03-15 | 2016-07-19 | Oakwood Laboratories LLC | High drug load buprenorphine microspheres and method of producing same |
| US9956177B2 (en) | 2013-03-15 | 2018-05-01 | Oakwood Laboratories LLC | Sustained release microspheres and method of producing same |
| US9636308B2 (en) | 2013-03-15 | 2017-05-02 | Oakwood Laboratories LLC | High drug load buprenorphine microspheres and method of producing same |
| RU2658004C2 (ru) * | 2013-06-20 | 2018-06-19 | Фарматен С.А. | Получение полилактидно-полигликолидных микрочастиц, характеризующихся сигмоидальным профилем высвобождения |
| CA3148303C (en) * | 2013-12-03 | 2024-02-27 | Intra-Cellular Therapies, Inc. | Heterocycle fused gamma-carboline compounds for use in treatment of bipolar disorders |
| US20150157628A1 (en) | 2013-12-11 | 2015-06-11 | Saravanan Kannusamy | Pharmaceutical compositions of Lurasidone and Process for preparation thereof |
| EP3242653A1 (en) | 2015-01-05 | 2017-11-15 | Boston Scientific Scimed Inc. | Biodegradable drug eluting microsphere for the treatment of solid tumors |
| WO2017059106A1 (en) | 2015-09-30 | 2017-04-06 | Indivior Uk Limited | Psychiatric treatment for patients with gene polymorphisms |
| WO2017119928A1 (en) | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long acting injectable formulations |
| WO2018015915A1 (en) * | 2016-07-22 | 2018-01-25 | Cadila Healthcare Limited | A parenteral controlled release composition of an atypical antipsychotic agent |
-
2022
- 2022-02-24 JP JP2023550249A patent/JP2024507528A/ja active Pending
- 2022-02-24 MX MX2023009754A patent/MX2023009754A/es unknown
- 2022-02-24 US US17/679,385 patent/US11992559B2/en active Active
- 2022-02-24 KR KR1020237032096A patent/KR20230157365A/ko active Pending
- 2022-02-24 WO PCT/US2022/070807 patent/WO2022183196A1/en not_active Ceased
- 2022-02-24 AU AU2022226584A patent/AU2022226584A1/en active Pending
- 2022-02-24 CA CA3210098A patent/CA3210098A1/en active Pending
- 2022-02-24 EP EP22760617.5A patent/EP4297753A4/en active Pending
-
2023
- 2023-07-23 IL IL304650A patent/IL304650A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mahar et al. | Application of PLGA as a biodegradable and biocompatible polymer for pulmonary delivery of drugs | |
| Domb et al. | Biodegradable polymers in clinical use and clinical development | |
| Mansour et al. | Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects | |
| US10463619B2 (en) | Injectable delivery of microparticles and compositions therefor | |
| JP2017141477A5 (enExample) | ||
| Patel et al. | Biodegradable polymers: emerging excipients for the pharmaceutical and medical device industries | |
| JP2005508893A5 (enExample) | ||
| JP2005510521A5 (enExample) | ||
| JP2005525403A5 (enExample) | ||
| CN106421800A (zh) | 丝素蛋白改性凹坑结构乳酸基聚合物载药微球及制备方法 | |
| CN105106174A (zh) | 一种核-壳双层微球及其制备方法 | |
| CN109414401A (zh) | 用于胃肠外给药的生物可降解聚合物微球组合物 | |
| Hosseini et al. | A review on synthesis, characterization and applications of polycaprolactone as a novel drug delivery system and tissue engineering | |
| Tsung et al. | Biodegradable polymers in drug delivery systems | |
| CN101522169B (zh) | 在延长的一段时间里释放活性成分的皮下植入剂 | |
| Koocheki et al. | Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride | |
| JPWO2007102447A1 (ja) | 付着型マイクロカプセル | |
| Al-Domi et al. | Development of an insulin nano-delivery system through buccal administration | |
| CN1437933A (zh) | 可生物降解性高分子材料包裹利福平微球的制备方法 | |
| Fulzele et al. | Novel Biopolymers as Implant Matrix for the Deliveryof Ciprofloxacin: Biocompatibility, Degradation, and In Vitro Antibiotic Release | |
| CN101810586B (zh) | 左旋多巴甲酯缓释微球组合物及其制备方法 | |
| Patel et al. | Poly lactic glycolic acid (PLGA) as biodegradable polymer | |
| US9216142B2 (en) | High-glass transition temperature absorbable microspheres | |
| Garg et al. | Enhancing periodontal defences with nanofiber treatment: recent advances and future prospects | |
| US20060286138A1 (en) | Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof |